Blood platelet volume to predict treatment-specific outcomes of metastatic castration-resistant prostate cancer.

Wataru Fukuokaya,Takahiro Kimura,Fumihiko Urabe,Shoji Kimura,Kojiro Tashiro,Shunsuke Tsuzuki,Yusuke Koike,Hiroshi Sasaki,Kenta Miki,Shin Egawa

Blood platelet volume to predict treatment-specific outcomes of metastatic castration-resistant prostate cancer.

2020

Wataru Fukuokaya
Takahiro Kimura
Fumihiko Urabe
Shoji Kimura
Kojiro Tashiro
Shunsuke Tsuzuki
Yusuke Koike
Hiroshi Sasaki
Kenta Miki
Shin Egawa

242Background: In the present guidelines for the management of metastatic castration-resistant prostate cancer (CRPC), it is unclear who benefits from androgen receptor axis-targeted agents (ARATs)...

Keywords:

Oncology
Castration
Mean platelet volume
Pathology
Prostate cancer
Internal medicine
Medicine
castration resistant
Androgen receptor

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations